Horseradish Peroxidase Biotinylated

CAT:
952-P2010010
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Horseradish Peroxidase Biotinylated - image 1

Horseradish Peroxidase Biotinylated

  • Description:

    Horseradish Peroxidase Biotinylated_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_
    Catalog number:P2010010
    Lot number:Batch Dependent
    Expiration date:Batch Dependent
    Package Size:1 mg
    Specific Activity:350 U/mg
    Unit Definition:Amount of biotinylated HRP needed to produce 1 μmole of purpurogallin from pyrogallol in 20 seconds at 20°C in reaction buffer: 8 mM hydrogen peroxide, 14 mM potassium phosphate, 0.5% pyrogallol, pH 6.0.
    Biotin Incorporation:1.3 moles biotin/mole HRP (HABA assay)
    Appearance:Lyophilized powder
    Storage:-20°C or lower. Avoid repeated freeze-thaw.
    Purity:>95%.
    Recommended Buffer:10 mM citrate, pH 6.0
    _x000D_  _x000D_ _x000D_ References Related to Horseradish Peroxidase Biotinylated_x000D_ _x000D_
      _x000D_
    • False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Piketty ML, Polak M, Flechtner I, Gonzales-Briceño L, Souberbielle JC. Clin Chem Lab Med. 2017 May 1;55(6):780-788.
    • _x000D_
    • Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays. Trambas C, Lu Z, Yen T, Sikaris K. Ann Clin Biochem. 2018 Mar;55(2):205-215.
    • _x000D_
    • Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays. Trambas C, Lu Z, Yen T, Sikaris K. Ann Clin Biochem. 2018 Mar;55(2):216-226.
    • _x000D_
    • Current good manufacturing practices-compliant manufacture and measurement of biotin-labeled red blood cells. Donnenberg AD, Kanias T, Triulzi DJ, Dennis CJ, Moore LR, Meyer EM, Sinchar D, Kiss JE, Normolle DP, Gladwin MT. Cytotherapy. 2019 Jul;21(7):793-800.
    • _x000D_
    • Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center. Stieglitz HM, Korpi-Steiner N. Clin Biochem. 2020 Jan;75:53-61.
    • _x000D_
    • Availability of NHS-biotin labeling to identify free protein lysine revealed by experiment and MD simulation. Muraoka A, Matsuura Y, Naitow H, Ihara M, Kunishima N. Anal Biochem. 2018 Sep 15;557:46-58.
    • _x000D_
    • Biotin accounts for less than half of all biotin and biotin metabolites in the cerebrospinal fluid of children. Bogusiewicz A, Stratton SL, Ellison DA, Mock DM. Am J Clin Nutr. 2008 Nov;88(5):1291-6.
    • _x000D_
    • Endogenous biotin in rat brain: implications for false-positive results with avidin-biotin and streptavidin-biotin techniques. McKay BE, Molineux ML, Turner RW. Methods Mol Biol. 2008;418:111-28.
    • _x000D_
  • Short Description:

    Catalog #: P2010010 - 1 mg
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5